The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam

Psychopharmacology

Volumn 231, Issue 15, 2014, Pages 2967-2979

  Wright, Brittany T ^a   Gluszek, Catherine F ^a   Heldt, Scott A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Benzodiazepines; Diazepam; GABA; Gene regulation; mRNA; Open field; Tolerance; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR DELTA; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; DIAZEPAM; GABA TRANSPORTER 1; GEPHYRIN; MESSENGER RNA; UNCLASSIFIED DRUG; ZOLPIDEM; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG EFFECT; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; WITHDRAWAL SYNDROME; ANIMAL; ANXIETY; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; DRUG TOLERANCE; EXPLORATORY BEHAVIOR; MALE; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANXIETY; BRAIN; DIAZEPAM; DRUG TOLERANCE; EXPLORATORY BEHAVIOR; GABA MODULATORS; GABA-A RECEPTOR AGONISTS; HYPNOTICS AND SEDATIVES; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GABA-A; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84904430959     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3473-x     Document Type: Article

References (122)

1. Acikmese B, Haznedar S, Hatipoglu I, Enginar N (2012) Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. Behav Pharmacol 23:215-219
2. Aitta-aho T, Vekovischeva OY, Neuvonen PJ, Korpi ER (2009) Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice. Pharmacol Biochem Behav 92:283-290
3. Ali NJ, Olsen RW (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABAA receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79:1100-1108 (Pubitemid 33117091)
4. Allison C, Pratt JA (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98:171-195 (Pubitemid 36513774)
5. Allison C, Claase LA, Pratt JA (2002) Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes. Behav Pharmacol 13:417-425 (Pubitemid 35178839)
6. Allison C, Pratt JA, Ripley TL, Stephens DN (2005) Alpha-amino-3-hydroxy- 5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam. Eur J Neurosci 21:1045-1056 (Pubitemid 40461056)
7. Aragona M (2000) Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report. Clin Neuropharmacol 23:281-283
8. Araujo F, Tan S, Ruano D, Schoemaker H, Benavides J, Vitorica J (1996) Molecular and pharmacological characterization of native cortical γ-aminobutyric acidA receptors containing both α1 and α3 subunits. J Biol Chem 271:27902-27911 (Pubitemid 26367368)
9. Arnot MI, Davies M, Martin IL, Bateson AN (2001) GABA(A) receptor gene expression in rat cortex: differential effects of two chronic diazepam treatment regimes. J Neurosci Res 64:617-625 (Pubitemid 32520684)
10. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch K-P, Schmitt A (2005) The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131:953-967 (Pubitemid 40320946)
11. Atack JR, Hutson PH, Collinson N, Marshall G, Bentley G, Moyes C, Cook SM, Collins I, Wafford K, McKernan RM, Dawson GR (2005) Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors. Br J Pharmacol 144: 357-366 (Pubitemid 40313682)
12. Auta J, Giusti P, Guidotti A, Costa E (1994) Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270: 1262-1269 (Pubitemid 24315248)
13. Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E (2008) Imidazenil: a low efficacy agonist at alpha1- but high efficacy at α5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 55:148-153
14. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International union of pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-314
15. Bateson AN (2002) Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8: 5-21
16. Benavides J, Peny B, Dubois A, Perrault G, Morel E, Zivkovic B, Scatton B (1988) In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. J Pharmacol Exp Ther 245:1033-1041
17. Benavides J, Peny B, Ruano D, Vitorica J, Scatton B (1993) Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 604:240-250 (Pubitemid 23080121)
18. Benca RM(2005) Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 56:332-343
19. Biggio G, Dazzi L, Biggio F, Mancuso L, Talani G, Busonero F, Mostallino MC, Sanna E, Follesa P (2003) Molecular mechanisms of tolerance to and withdrawal of GABAA receptormodulators. Eur Neuropsychopharmacol 13:411-423 (Pubitemid 37433962)
20. Blanchard DC, Griebel G, Blanchard RJ (2001) Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25:205-218 (Pubitemid 32506874)
21. Burt DR, Kamatchi GL (1991) GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J 5:2916-2923 (Pubitemid 21905832)
22. Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF (1997) Special Report: the 1996 guide for the care and use of laboratory animals. The National Academies Press, Bethesda, MD
23. Cohen C, Sanger DJ (1994) Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps. Psychopharmacology (Berl) 115:86-94 (Pubitemid 24207766)
24. Crestani F, Löw K, Keist R, Mandelli M-J, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445 (Pubitemid 32179921)
25. Cubala WJ, Landowski J (2007) Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 31:539-540 (Pubitemid 46209407)
26. Davis M (2000) The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton JP (ed) The amygdala: A functional analysis. Oxford University Press, New York, pp 213-287
27. Diaz-Garcia JM, Oliver-Botana J, Fos-Galve D (1992) Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury. J Pharm Sci 81:768-772 (Pubitemid 23006815)
28. Divljaković J, Milić M, Namjoshi OA, Tiruveedhula VV, Timić T, Cook JM, Savić MM (2013) β CCT, an antagonist selective for α1GABAA receptors, reverses diazepam withdrawal-induced anxiety in rats. Brain Res Bull 91:1-7
29. Drover DR (2004) Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 43:227-238
30. Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, Morrow AL (1995) Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience 64:1113-1128
31. Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY (1998) Species differences in regional patterns of 3H-8-OH-DPAT and 3Hzolpidem binding in the rat and human brain. Pharmacol Biochem Behav 60:439-448 (Pubitemid 28282685)
32. Ebert B, Anderson NJ, Cremers TI, Rasmussen S, Vogel V, Fahey JM, Sánchez C (2008) Gaboxadol - a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing. Pharmacol Biochem Behav 90:113-122
33. Elliot EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol Biochem Behav 66:361-369 (Pubitemid 30394624)
34. Fahey JM, Pritchard GA, Grassi JM, Pratt JS, Shader RI, Greenblatt DJ (1999) In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration. J Psychopharmacol 13:211-218 (Pubitemid 29435779)
35. Fernandes C, File SE, Berry D (1996) Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects. Brain Res Bull 734:236-242 (Pubitemid 26334051)
36. Fernandes C, Arnot MI, Irvine EE, Bateson AN, Martin IL, File SE (1999) The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) 145:251-259 (Pubitemid 29393474)
37. File SE (1985) Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev 9:113-121
38. File SE (1990) The history of benzodiazepine dependence: a review of animal studies. Neurosci Biobehav Rev 14:135-146
39. Follesa P, Cagetti E, Mancuso L, Biggio F, Manca A, Maciocco E, Massa F, Desole MS, Carta M, Busonero F, Sanna E, Biggio G (2001) Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-termtreatment with, benzodiazepine full or partial agonists. Brain Res Mol Brain Res 92:138-148 (Pubitemid 32718713)
40. Friedman H, Abernethy DR, Greenblatt DJ, Shader RI (1986) The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology (Berl) 88:267-270 (Pubitemid 16131107)
41. Galpern WR, Lumpkin M, Greenblatt DJ, Shader RI, Miller LG (1991) Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacology (Berl) 104:225-230
42. Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thenot JP, Morselli PL (1989) Pharmacokinetics, brain distribution and pharmaco- electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248:1283-1288 (Pubitemid 19100785)
43. Gericke CA, Ludolph AC (1994) Chronic abuse of zolpidem. JAMA 272:1721-1722 (Pubitemid 24371987)
44. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386-401 (Pubitemid 34164011)
45. Glisovic T, Bachorik JL, Yong J, Dreyfuss G (2008) RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 582:1977-1986
46. Gravielle MC, Faris R, Russek SJ, Farb DH (2005) GABA induces activity dependent delayed - onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons. J Biol Chem 280:20954-20960 (Pubitemid 40805652)
47. Greenblatt DJ, Roth T (2012) Zolpidem for insomnia. Expert Opin Pharmacother 13:879-893
48. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ (1999) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) 146:205-213 (Pubitemid 29474214)
49. Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals - implications for problems of longterm use and abuse. Psychopharmacology (Berl) 134:1-37 (Pubitemid 27485546)
50. Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199-1208
51. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371-1378 (Pubitemid 37297243)
52. Heikkinen AE, Moykkynen TP, Korpi ER (2009) Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology 34:290-298
53. Heldt SA, Ressler KJ (2007) Forebrain andmidbrain distribution ofmajor benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience 150:370-385 (Pubitemid 350198707)
54. Heninger C, Saito N, Tallman JF, Garrett KM, Vitek MP, Duman RS, Gallager DW (1990) Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain. J Mol Neurosci 2:101-107
55. Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM (2007) Projecting future drug expenditures-2007. Am J Health Syst Pharm 64:298-314
56. Holt RA, Bateson AN, Martin IL (1996) Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology 35:1457-1463 (Pubitemid 27013880)
57. Holt RA, Bateson AN, Martin IL (1997) Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol 329:129-132
58. Huang MC, Lin HY, Chen CH (2007) Dependence on zolpidem. Psychiatry Clin Neurosci 61:207-208
59. Huopaniemi L, Keist R, Randolph A, Certa U, Rudolph U (2004) Diazepam-induced adaptive plasticity revealed by α1 GABAA receptor-specific expression profiling. J Neurochem 88:1059-1067 (Pubitemid 38280674)
60. Impagnatiello F, Pesold C, Longone P, Caruncho H, Fritschy JM, Costa E, Guidotti A (1996) Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49:822-831
61. IMS-Health (2011) National (VONA) and total patient tracker (TPT). MS Health, Fairfield, CT
62. Jacob TC, Michels G, Silayeva L, Haydon J, Succol F, Moss SJ (2012) Benzodiazepine treatment induces subtype-specific changes in GABAA receptor trafficking and decreases synaptic inhibition. Proc Natl Acad Sci USA 109:18595-18600
63. Jardim MC, Nogueira RL, Graeff FG, Nunes-de-Souza RL (1999) Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Res Bull 48:407-411 (Pubitemid 29234856)
64. Kang I, Miller LG (1991) Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br J Pharmacol 103:1285-1287
65. King DA, Bouton ME, Musty RE (1987) Associative control of tolerance to the sedative effects of a short-acting benzodiazepine. Behav Neurosci 101:104-114 (Pubitemid 17028959)
66. Kittler JT, Delmas P, Jovanovic JN, Brown DA, Smart TG, Moss SJ (2000) Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci 20:7972-7977
67. Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Luddens H (2002) Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience 109:733-743 (Pubitemid 34260857)
68. Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42
69. Lader M (2011) Benzodiazepines revisited-will we ever learn? Addiction 106:2086-2109
70. Lau CE, Sun L, Wang Q, Falk JL (2002) The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations. Behav Pharmacol 13:93-103 (Pubitemid 34450695)
71. Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou CK, Christodoulou GN (2003) Zolpidemdependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 17:131-135 (Pubitemid 36373152)
72. Longone P, Impagnatiello F, Guidotti A, Costa E (1996) Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology 35:1465-1473 (Pubitemid 27013881)
73. Loscher W, Schwark WS (1985) Development of tolerance to the anti-convulsant effect of diazepam in amygdala-kindled rats. Exp Neurol 90:373-384 (Pubitemid 16225322)
74. Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
75. Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163-171 (Pubitemid 14138266)
76. Marin RH, Pérez MF, Duero DG, Ramirez OA (1999) Preexposure to drug administration context blocks the development of tolerance to sedative effects of diazepam. Pharmacol Biochem Behav 64:473-477 (Pubitemid 29488472)
77. Markowitz GJ, Kadam SD, Boothe DM, Irving ND, Comi AM (2010) The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice. Neuroreport 21:452-456
78. McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139-143
79. Mehta AK, Ticku MK (1999) Prevalence of the GABAA receptor assemblies containing alpha1-subunit in the rat cerebellum and cerebral cortex as determined by immunoprecipitation: lack of modulation by chronic ethanol administration. Brain Res Mol Brain Res 67:194-199 (Pubitemid 29170084)
80. Metten P, Belknap JK, Crabbe JC (1998) Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 95:113-122 (Pubitemid 28400377)
81. Miller LG, Woolverton S, Greenblatt DJ, Lopez F, Roy RB, Shader RI (1989) Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol 38:3773-3777 (Pubitemid 19284026)
82. Murphy HM, Ihekoronze C, Wideman CH (2011) Zolpidem-induced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav 98:81-86
83. Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487-494 (Pubitemid 20357499)
84. Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298-303
85. Pesold C, Caruncho HJ, Impagnatiello F, Berg MJ, Fritschy JM, Guidotti A, Costa E (1997) Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areas. Neuroscience 79:477-487 (Pubitemid 27232404)
86. Petroski RE, Pomeroy JE, Das R, Bowman H, Yang W, Chen AP, Foster AC (2006) Indiplon is a high-affinity positive allosteric modulator with selectivity for α1 subunit-containing GABAA receptors. J Pharmacol Exp Ther 317:369-377
87. Petursson H (1994) The benzodiazepine withdrawal syndrome. Addiction 89:1455-1459
88. Pieri L, Schaffner R, Scherschlicht R, Polc P, Sepinwall J, Davidson A, Mohler H, Cumin R, Da Prada M, Burkard WP, Keller HH, Muller RK, Gerold M, Pieri M, Cook L, Haefely W (1981) Pharmacology of midazolam. Arzneimittelforschung 31:2180-2201 (Pubitemid 12222296)
89. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101:815-850
90. Pugh SL, Boone MS, Emmett-Oglesby MW (1992) Tolerance, crosstolerance and withdrawal in rats made dependent on diazepam. J Pharmacol Exp Ther 262:751-758
91. Renger JJ, Dunn SL, Motzel SL, Johnson C, Koblan KS (2004) Subchronic administration of zolpidem affects modifications to rat sleep architecture. Brain Res 1010:45-54 (Pubitemid 38569851)
92. Roehrs TA, Randall S, Harris E, Maan R, Roth T (2012) Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol 26:1088-1095
93. Sanger DJ, Zivkovic B (1987) Investigation of the development of tolerance to the actions of zolpidem and midazolam. Neuropharmacology 26:1513-1518 (Pubitemid 17149594)
94. Sanger DJ, Zivkovic B (1992) Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology 31:693-700
95. Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Biggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes. Eur J Pharmacol 451:103-110 (Pubitemid 35253948)
96. Schmid L, Bottlaender M, Fuseau C, Fournier D, Brouillet E, Mazière M (1995) Zolpidem displays heterogeneity in its binding to the non-human primate benzodiazepine receptor in vivo. J Neurochem 65:1880-1886
97. Sethi PK, Khandelwal DC (2005) Zolpidemat supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. J Assoc Physicians India 53:139-140 (Pubitemid 41280119)
98. Siegel S (1989) Pharmacological conditioning and drug effects. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: Tolerance and sensitization. Humana Press, Totowa, pp 115-180
99. Smith PF, Darlington CL (1994) The behavioural effects of long-term use of benzodiazepine sedative and hypnotic drugs: what can be learned from animal studies? N Z J Psychol 23:48-63
100. Smith R, Wright BT, Heldt SA (2011) Tolerance and withdrawal effects of zolpidem in mice given chronic zolpidem treatment Society for Neuroscience. Neuroscience Meeting Planner, Washington, DC
101. Steppuhn KG, Turski L (1993) Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 90:6889-6893 (Pubitemid 23207319)
102. Tietz EI, Huang X, Chen S, Ferencak Iii WF (1999) Temporal and regional regulation of α1, β2 and β3, but not α2, α4, α5, α6, β1 or γ2 GABAA receptor subunit messenger RNAs following one-week oral flurazepam administration. Neuroscience 91:327- 341
103. Trenque T, Bustany P, Lamiable D, Legros S, Choisy H (1994) Pharmacokinetics and brain distribution of zolpidem in the rat after acute and chronic administration. J Pharm Pharmacol 46:611-613 (Pubitemid 24213292)
104. Uusi-Oukari M, Korpi ER (2010) Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev 62: 97-135
105. van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, Fritschy JM, Crestani F (2004) Requirement of α5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24:6785-6790 (Pubitemid 38993900)
106. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198-209 (Pubitemid 47063241)
107. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol 1-8
108. Vinkers CH, Olivier B (2012) Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABAA receptor modulators? Adv Pharmacol Sci. doi:10.1155/2012/416864
109. Vinkers CH, van Oorschot R, Nielsen EO, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR (2012) GABA(A) receptor alpha subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS ONE 7:e43054. doi:10.1371/journal.pone.0043054PONE-D-11-24285
110. Vlainic J, Pericic D (2009) Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 56:1124-1130
111. Vogel HG, Vogel WH (2002) Drug discovery and evaluation: pharmacological assays. Springer, New York
112. VonVoigtlander PF, Lewis RA (1991) A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists. J Pharmacol Methods 26:1-5
113. Voss J, Sanchez C, Michelsen S, Ebert B (2003) Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance. Eur J Pharmacol 482: 215-222 (Pubitemid 37505947)
114. Walker MC, Tong X, Brown S, Shorvon SD, Patsalos PN (1998) Comparison of single- and repeated-dose pharmacokinetics of diazepam. Epilepsia 39:283-289 (Pubitemid 28141308)
115. Ward BO, Stephens DN (1998) Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensi t ivity. Psychopharmacology 135:342-352 (Pubitemid 28254840)
116. Weerts EM, Griffiths RR (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav Pharmacol 9:285-297 (Pubitemid 28273114)
117. Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41-53 (Pubitemid 28207568)
118. Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12:1040-1062
119. Wu Y, Rosenberg HC, Chiu TH, Ramsey-Williams V (1994) Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding. J Pharmacol Exp Ther 268:675-682 (Pubitemid 24085863)
120. Yanagita T, Takahashi S (1973) Dependence liability of several sedativehypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185: 307-316
121. Zamanillo D, Sprengel R, Hvalby Ø, Jensen V, Burnashev N, Rozov A, Kaiser KMM, Köster HJ, Borchardt T, Worley P, Lübke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284:1805-1811
122. Zhao TJ, Chiu TH, Rosenberg HC (1994) Reduced expression of gamma-aminobutyric acid type A/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats. Mol Pharmacol 45:657-663